They reported that docetaxel treatment reduced tumor growth significantly in tumors derived from LuCaP 86.2 cells, while tumors derived from LuCaP 23.1 did not show tumor growth reduction, suggesting that docetaxel affects the AR splice variants differently. Here, AR is linked to neoplasm.